The AutoMicrobic System Enterobacteriaceae Biochemical Card (AMS-EBC; Vitek Systems, Inc.) was (1, 2, 5, 9) , no further evaluation of these products was made. Isolates that showed discrepancies when tested with the three systems were examined at the Houston City Health Department Laboratories by the conventional methods of Edwards and Ewing (6) and Ewing and Martin (7).
correctly identified 96.6% and incorrectly identified 3.4% of the isolates. When 12 or more isolates of a species were evaluated, Serratia marcescens, Proteus mirabilis, and Enterobacter cloacae posed the greatest challenge to the system, with 92.6, 95.2, and 95.3%, respectively, being correctly identified. To confirm the accuracy of identification when all systems agreed, 93 randomly selected isolates were identified by conventional methods. The percent agreement was 100%. The reproducibility of triplicate determinations on 93 randomly selected isolates with the AMS-EBC was 99.6%. The AMS-EBC was found to be an easy, rapid, and accurate method for identification of Enterobacteriaceae.
Within the past 10 years, there have been many advances in miniaturized and semiautomated techniques for the identification of microorganisms, particularly members of the family Enterobacteriaceae (1-5, 8, 9, 11-14) . Vitek Systems, Inc., recently introduced the AutoMicrobic System Enterobacteriaceae Biochemical Card (AMS-EBC; 10) that allows a fully automated approach to the identification of En- terobacteriaceae. This report presents the results of an evaluation of AMS-EBC for its accuracy in identification of fermentative, gramnegative bacilli.
MATERIALS AND METHODS Organisms. A total of 502 consecutive clinical isolates representing members of the family Enterobacteriaceae were obtained from two clinical microbiology laboratories in the Texas Medical Center. All organisms were assigned a numerical code, and the identity of the organisms was unknown during the evaluation.
Identification methods. All organisms were identified in parallel by use of the AMS-EBC (Vitek Systems, Inc., subsidiary of McDonnell-Douglas, Hazelwood, Mo.), API 20E (Analytab Products, Plainview, N.Y.), and Enterotube II systems (Roche Diagnostics, Div. Hoffman-La Roche, Inc., Nutley, N.J.). The API 20E and Enterotube II systems were inoculated, incubated, and read according to the manufacturer's instructions. Since the performance characteristics of the API 20E and Enterotube II systems are well established (1, 2, 5, 9) , no further evaluation of these products was made. Isolates that showed discrepancies when tested with the three systems were examined at the Houston City Health Department Laboratories by the conventional methods of Edwards and Ewing (6) and Ewing and Martin (7) .
Ninety-three randomly selected isolates that demonstrated complete agreement between the three test systems were identified by conventional methods to confirm their identification. These same 93 isolates were identified by AMS-EBC on three separate occasions to determine the reproducibility of the system. Inoculum preparation. After approximately 24 h of incubation, several colonies were selected from primary culture plates of blood agar or MacConkey agar and suspended in 1.8 ml of 0.5% NaCl to a density equivalent to a McFarland no. 1 standard. This suspension was used to inoculate the AMS-EBC. A loopful of this suspension was also streaked onto blood agar and incubated overnight at 35°C for use in the inoculation of the API 20E and Enterotube II systems.
AMS-EBC. The AMS-EBC, a 30-compartment card containing 26 dried biochemical broths and a growth control broth, was previously described (10) . The AMS-EBC was marked for computer recognition and then attached to the single-barreled card sample 370 injector. The inoculum was transferred from the injector into the AMS-EBC by the vacuum chamber that is a part of the system. The AMS-EBC was inspected to verify that it filled properly and then placed in the reader/incubator for analysis. Within 8 h, members of the Enterobacteriaceae were identified. All biochemical reactions and a probability number for the identification were printed automatically at the 8-h reading. The computer also provided the next-most-probable identification.
The computerized data base for the AMS-EBC was developed independently of the classical reactions of Edwards and Ewing (6) . The development of an independent data base was necessary since the formulation of some of the media in the AMS-EBC, as well as inoculum density, volume within each well, passage of atmospheric gases, and length of incubation, differed from that of conventional methods. Consequently, the results obtained from the AMS-EBC are not expected or required to correlate always with those produced by conventional methods. Therefore, a testby-test comparison of individual reactions appeared to be of limited value and thus was not performed. The evaluation was designed and conducted to determine the overall accuracy of identification by AMS-EBC.
RESULTS
A total of 502 members of the family Enterobacteriaceae representing 10 genera were tested. The distribution of these clinical isolates is shown in Table 1 by organism identification.
AMS-EBC correctly identified 96.6% of the clinical isolates tested in this evaluation (Table  1) . Seventeen organisms (3.4%) were incorrectly identified. None ofthe organisms studied yielded inconclusive results.
Escherichia coli and Klebsiella pneumoniae were the predominant organisms and were correctly identified at 98.9 and 100%, respectively. When 12 or more isolates of a species were evaluated, Serratia marcescens, Proteus mirabilis, and Enterobacter cloacae posed the greatest challenge to the system, with 92.6, 95.2, and 95.3% of the strains, respectively, being correctly identified. These isolates represented 41.2% of the total identification errors. Two isolates of Klebsiella ozaenae and one each of Enterobacter agglomerans, Enterobacter sakazakii, Citrobacter amalonaticus, and Shigella flexneri biotype 6 were incorrectly identified. It should be pointed out that E. sakazakii and C. amalonaticus were not in the AMS-EBC data base, and, when the cultures were evaluated with the expanded AMS-EBC plus data base, they were correctly identified.
The accuracy of the AMS-EBC (96.6%) was equivalent to those of the API 20E and Enterotube II systems at 97.2 and 97.8%, respectively. At the genus and species level of identification, the three methods agreed in 473 of the 502 isolates, or 94.2% (Table 2) . Two of the three methods agreed in a further 4.4% of isolates (98.6%). When identification was taken only to the genus level, there was complete agreement with 95.2% of the isolates.
When two of the three systems produced the same identification, AMS-EBC was found to disagree 12 out of 22 times (Table 3) . In all but three cases, when the results of any two systems yielded the same genus and species, the identification agreed with that obtained by conventional methods. The three exceptions were two K. pneumoniae and one E. agglomerans. In these three cases, none of the three systems gave the correct answer.
Discrepancies in AMS-EBC identification are shown in Table 4 . Three P. mirabilis were identified as Morganella morganii. All reactions necessary to identify these organisms as P. mirabilis correlated with conventional testing, except for a negative xylose reaction by AMS-EBC.
Two S. marcescens were identified as Serratia 10 1 Two E. cloacae showed discrepancies in the AMS-EBC analysis. False-negative arginine and false-positive lysine decarboxylase reactions led to the designation of S. liquefaciens, which is characteristically negative for arginine at a 99% level and positive for lysine 64% of the time. Arginine should be positive in 60% of reactions with E. cloacae, whereas lysine should be negative in 99% of reactions.
The other isolate of E. cloacae was identified
as an E. agglomerans. Arginine was positive by AMS-EBC and conventional tests, thus favoring E. cloacae, since only 1% of E. agglomerans are arginine positive. Sorbitol and melibiose reactions were negative by AMS-EBC and conventional testing, and this result would favor E. agglomerans. False-negative raffinose fermentation was probably the pivotal reaction resulting in misidentification, since 90% of E. cloacae are raffinose-positive versus only 24% for E. agglomerans. One strain of E. agglomerans was identified by AMS-EBC as an E. cloacae. The substrates involved in this misidentification were positive reactions for ornithine decarboxylase and arginine. Therefore, the reaction file in AMS-EBC yielded an identification of E. cloacae which is positive for ornithine and arginine at a 93 and 90% level, respectively. Ornithine and arginine are negative at a level of 99% for E. agglomerans.
There were two misidentifications of C. freundii. One isolate of C. freundii was identified as E. agglomerans by AMS-EBC. Five incorrect reactions were found when compared with conventional biochemicals. However, false-negative H2S and arginine reactions were key reactions that led to the incorrect identification of E. agglomerans, with a probability of 57% as compared with 42% for C. freundii. Only 1% of E. agglomerans are positive for these two substrates, whereas C. freundii is positive for H2S and arginine at 79 and 46%, respectively.
The other isolate of C. freundii was identified by AMS-EBC as E. cloacae. When compared with conventional biochemicals, false-negative arginine, inositol, and rhamnose reactions were noted. These reactions were not critical to the identification of C. freundii. A positive plant indican and a negative DP 300 reaction were probably responsible for the misidentification as E. cloacae. The three isolates were H2S negative and xylose negative by AMS-EBC but were H2S negative and xylose positive by conventional testing. The false-negative xylose reaction by AMS-EBC, which according to the AMS-EBC data base is 99% negative for M. morganii, was the pivotal reaction resulting in misidentification.
Two isolates of K. ozaenae were misidentified by AMS-EBC. In one instance, the organism was identified as an E. agglomerans with a probability of 63%. K. ozaenae was listed as a second choice at 32%. False-negative malonate, lysine, inositol, and xylose reactions by AMS-EBC were found when compared with conventional biochemicals.
In the second instance, K. ozaenae was identified as K. pneumoniae. This isolate produced false-positive malonate, urea, and citrate reactions when compared with the reactions obtained by conventional biochemical testing. Ninety-two and 50% of K. pneumoniae are malonate positive and urea positive, respectively, versus only 4 and 1%, respectively, for K. ozaenae; these two reactions were primarily responsible for this misidentification.
There were two misidentifications of E. coli by AMS-EBC. One of these isolates was identified as C. freundii. False-positive DP 300, urea, citrate, and H2S reactions resulted in this misidentification. The other isolate of E. coli was identified as Salmonella typhi. This strain of E.
coli was lactose and o-nitrophenyl-,8-D-galactopyranoside negative by both AMS and conventional biochemicals. However, false-negative sorbitol, rhamnose, and raffinose reactions by AMS-EBC resulted in misidentification as S. typhi. Sorbitol, rhamnose, and raffinose were positive in only 1% of S. typhi versus 93, 83, and 49%, respectively, for E. coli All three carbohydrates were positive at 48 h when tested with conventional biochemicals.
One strain of C. amalonaticus was identified by AMS-EBC as a Salmonella species as a result of false-negative o-nitrophenyl-,f-D-galactopyranoside, lactose, urea, and arginine reactions. The first two biochemicals were key reactions that resulted in misidentification. In addition, the plant indican and DP 300 reactions were negative. Only 1% of Salmonella species are positive for these latter two reactions. C. amalonaticus was not in the AMS-EBC data base. Repeat of this isolate with the AMS-EBC plus data base correctly identified the organism as C. A detailed discussion of the performance characteristics of the AMS-EBC was presented by Isenberg et al. (10) and will not be repeated here. We did, however, make the following relevant observations in our evaluation. Two or more false-negative biochemical reactions on AMS-EBC were noted with single isolates of E. sakazakii, E. cloacae, C. freundii, K. ozaenae, E. coli, and C. amalonaticus and resulted in misidentification of these organisms. Two or more false-positive biochemical reactions on AMS-EBC were noted with single isolates of E. agglomerans, K. ozaenae, and E. coli and resulted in misidentification of these organisms. These discrepancies were not common to any species and probably were the result of either too light or heavy inocula, respectively. Therefore, 9 of the 17 discrepancies observed with AMS-EBC were probably the result of inoculum error.
S. flexneri biotype 6, which is mannitol negative, would be identified as S. dysenteriae with the current AMS-EBC data base. Inclusion of dulcitol in the reaction file would have allowed identification of this organism as either S. flexneri biotype 6 or S. dysenteriae biotype 5.
The criterion used in this study for correct identification was 100% agreement for the three systems. To establish the validity of this assumption, 93 such isolates were identified by conventional biochemicals. The identifications obtained by conventional testing agreed with the three test systems in all cases. In fact, the identification of 19 of 22 isolates for which only two of the three systems agreed was substantiated by conventional testing (86.4%).
The reproducibility of the AMS-EBC in 279 determinations on 93 isolates was 99.6%. The one error observed was probably due to a bad EBC, rather than any inherent problem within either the equipment or the computer program.
The results produced by the three commercial systems were essentially equivalent. The AMS-EBC significantly reduces the time required to identify the Enterobacteriaceae and requires no technologist time for interpretation and recording of results, as do the other two systems. The automation of these functions also reduces the opportunity for human error. The ability of the AMS-EBC to yield the same result on repeat testing was outstanding at 99.6%. The capability of the AMS-EBC to identify accurately members of the Enterobacteriaceae coupled with the ability of the AMS to provide other automated functions such as urine microbiology, identification of nonfermentative gram-negative bacilli, antimicrobial susceptibility testing, and yeast identification, indicate that the AMS is a major advancement in automation of clinical microbiology.
